Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
02/2012
02/29/2012CN101628903B Defervescence anti-inflammatory and anti-infection medicine with immunization function, preparation and application thereof
02/29/2012CN101590152B Preparation method of Bawei Chenxiang capsule
02/29/2012CN101579394B Trichosanthes bark dropping pill and preparation method thereof
02/29/2012CN101530500B Application of blood-nourishing and brain-refreshing granules in preparing medicine for reducing cerebral infarction
02/29/2012CN101524514B Medicament for curing central serous chorioretinopathy (CSCR) and preparation method thereof
02/29/2012CN101480472B Medicament for reducing blood pressure and regulating blood fat and production method
02/29/2012CN101400659B Novel 1,2,3,4-tetrahydroquinoxaline derivative having glucocorticoid receptor binding activity
02/29/2012CN101357119B Medicine microemulsion injection composition and preparation method thereof
02/29/2012CN101279081B Chinese medicine for improving microcirculation and immunity of human body and processing method
02/29/2012CN101239151B Chinese medicine for preventing and controlling cardiovascular and cerebrovascular diseases and preparation method thereof
02/29/2012CN101208328B Heteroaryl-substituted amides comprising a saturated linker group, and their use as pharmaceuticals
02/28/2012US8124646 Substituted isoindoline-1,3-dione derivatives
02/28/2012US8124644 Carvedilol phosphate
02/28/2012US8124638 Tricyclic compounds useful as angiotensin II agonists
02/28/2012US8124586 Prevention and reduction of blood loss
02/28/2012US8124122 Female hormone-containing patch
02/28/2012US8124074 Fusion proteins
02/28/2012US8124057 Propellant-based nanoparticulate dry powder aerosols and method of making
02/28/2012CA2333951C Method for treating neurodegenerative disorders
02/23/2012WO2012024638A2 Compositions and methods for treating obesity and related disorders by characterizing and restoring mammalian bacterial microbiota
02/23/2012WO2012024530A2 Therapeutic peptide-polymer conjugates, particles, compositions, and related methods
02/23/2012WO2012024452A2 Modified relaxin polypeptides and their uses
02/23/2012WO2012024150A1 Oxadiazole inhibitors of leukotriene production
02/23/2012WO2012023810A2 Pharmaceutical composition for promoting angiogenesis, and method for screening for active substances for promoting angiogenesis
02/23/2012WO2012023254A1 Novel anti-inflammatory metabolite derived from omega-3-type fatty acid
02/23/2012WO2012022896A1 Pharmaceutical composition for the prevention of perioperative arterial hypotension in humans
02/23/2012WO2012022121A1 Fused ring compound for use as mineralocorticoid receptor antagonist
02/23/2012WO2012022120A1 Dihydropyrazole compounds
02/23/2012WO2012003554A3 Compositions and methods for removal or destruction of amyloid fibril or amyloid adhesin comprising aggregates
02/23/2012WO2011115447A3 C-terminal truncated peroxiredoxin-ii, and composition for preventing and treating apoptosis containing same
02/23/2012WO2011106674A3 Use of endogenous antioxidant proteins in the treatment of stroke
02/23/2012US20120046441 Combinatorial Synthesis of Libraries of Macrocyclic Compounds Useful in Drug Discovery
02/23/2012US20120046368 Method for purifying 3,4-dihydroxyphenylglycol (dhpg) from plant products
02/23/2012US20120046366 Extractions of Fixed Oil and Thymoquinone Rich Fractions (TQRF)
02/23/2012US20120046364 Novel Sulfonic Acid-Containing Thyromimetics, and Methods for Their Use
02/23/2012US20120046363 Docosahexaenoic acid for the treatment of heart failure
02/23/2012US20120046357 Benzamide and Napthamide Derivatives Inhibiting Nuclear Factor-Kappa (B) - (NK-kB)
02/23/2012US20120046356 New process for preparing diketones and medicaments
02/23/2012US20120046349 Compositions for targeting conducting airway cells comprising adeno-associated virus constructs
02/23/2012US20120046347 Expression of apoai and variants thereof using spliceosome mediated rna trans-splicing
02/23/2012US20120046345 Treatment of dystrophin family related diseases by inhibition of natural antisense transcript to dmd family
02/23/2012US20120046344 Treatment of lipid transport and metabolism gene related diseases by inhibition of natural antisense transcript to a lipid transport and metabolism gene
02/23/2012US20120046343 MULTI-TARGETING SHORT INTERFERING RNAs
02/23/2012US20120046330 Pharmaceutical compositions of (r)-1-(2,2-difluorobenzo[d] [1,3]dioxol-5-yl)-n-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1h-indol-5-yl) cyclopropanecarboxamide and administration thereof
02/23/2012US20120046329 Modulators of nod1 and nod2 signaling, methods of identifying modulators of nod1 and nod2 signaling, and uses thereof
02/23/2012US20120046325 Isoxazoline Compounds Having MIF Antagonist Activity
02/23/2012US20120046322 Bioavailable Diacylhydrazine Ligands for Modulating the Expression of Exogenous Genes via an Ecdysone Receptor Complex
02/23/2012US20120046321 Methods of treating atrial fibrillation with p38 inhibitor compounds
02/23/2012US20120046317 Novel heterocyclic compounds
02/23/2012US20120046311 Chemokine receptor antagonists and methods of use thereof
02/23/2012US20120046308 Novel alpha-phenoxybenzeneacetic acid derivative and pharmaceutical preparation comprising same
02/23/2012US20120046307 Allosteric protein kinase modulators
02/23/2012US20120046304 Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation
02/23/2012US20120046303 Benzimidazole poly(adp ribose)polymerase inhibitors
02/23/2012US20120046301 Substituted Cyclic Carboxamide and Urea Derivatives as Ligands of the Vanilloid Receptor
02/23/2012US20120046299 Method of treating arrhythmias
02/23/2012US20120046293 Renin inhibitors
02/23/2012US20120046286 Novel Compounds
02/23/2012US20120046285 Bradykinin receptor agonists and uses thereof to treat ocular hypertension and glaucoma
02/23/2012US20120046280 Novel heteropyrrole analogs acting on cannabinoid receptors
02/23/2012US20120046274 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors
02/23/2012US20120046269 Novel Amino Azaheterocyclic Carboxamides
02/23/2012US20120046255 Non-steroidal compounds
02/23/2012US20120046252 Calcium Formate for Use as a Dietary Supplement
02/23/2012US20120046249 Methods of reducing the risk of cardiovascular disease in postmenopausal women
02/23/2012US20120046243 Aminopyridine- and Aminopyrimidinecarboxamides as CXCR2 Modulators
02/23/2012US20120046237 Compositions for protection against superficial vasodilator flush syndrome, and methods of use
02/23/2012US20120046236 Treatment of tristetraproline (ttp) related diseases by inhibition of natural antisense transcript to ttp
02/23/2012US20120046230 Combination Anticoagulant Therapy With A Compound That Acts As A Factor Xa Inhibitor
02/23/2012US20120046229 Modified relaxin polypeptides and their uses
02/23/2012US20120046219 Melanocortin receptor-specific peptides
02/23/2012US20120046218 Glycosaminoglycan-antagonising mcp-i mutants and methods of using same
02/23/2012US20120046217 TNF-alpha Antagonists Containing IGFBP5
02/23/2012US20120045774 Lipoprotein Associated Phospholipase A2, Inhibitors Thereof and Use of the Same in Diagnosis and Therapy
02/23/2012US20120045507 Stable soft capsule dosage form for acetylsalicylic acid
02/23/2012US20120045505 Fixed dose drug combination formulations
02/23/2012US20120045503 Compositions And Methods For Wound Healing
02/23/2012US20120045500 Novel dioxo-imidazolidine derivatives, which inhibit the enzyme soat-1, and pharmaceutical and cosmetic compositions containing them
02/23/2012US20120045487 Multiphasic microfibers for spatially guided cell growth
02/23/2012US20120045462 Inflammation Inhibiting Compounds
02/23/2012US20120045459 Methods for Treating Autophagy-Related Disorders
02/23/2012US20120045452 Mnk KINASE HOMOLOGOUS PROTEINS INVOLVED IN THE REGULATION OF ENERGY HOMEOSTASIS AND ORGANELLE METABOLISM
02/23/2012US20120045451 Mnk KINASE HOMOLOGOUS PROTEINS INVOLVED IN THE REGULATION OF ENERGY HOMEOSTASIS AND ORGANELLE METABOLISM
02/23/2012US20120045443 Agonist anti-trk-c monoclonal antibodies
02/23/2012US20120045441 Methods of treating lung disease and other inflammatory diseases
02/23/2012US20120045438 Engineered anti-il-13 antibodies, compositions, methods and uses
02/23/2012US20120045435 Compositions and methods to inhibit stem cell and progenitor cell binding to lymphoid tissue and for regenerating germinal centers in lymphatic tissues
02/23/2012US20120045430 Dendrimer-like modular delivery vector
02/23/2012US20120045428 Methods for preparing a fermented ginseng concentrate or powder
02/23/2012US20120045426 Compositions for reducing the deleterious effects of stress and aging
02/23/2012US20120045421 Methods for the isolation of cardiac stem cells
02/23/2012US20120045394 Human and mouse targeting peptides identified by phage display
02/23/2012CA2844109A1 Compositions and methods to inhibit stem cell and progenitor cell binding to lymphoid tissue and for regenerating germinal centers in lymphatic tissues
02/23/2012CA2808678A1 Fused ring compound for use as mineralocorticoid receptor antagonist
02/23/2012CA2807364A1 Oxadiazole inhibitors of leukotriene production
02/23/2012CA2803349A1 Composition pharmaceutique pour la prevention de l'hypotension arterielle peroperatoire chez l' etre humain
02/22/2012EP2420502A1 Fused pyrrolopyridine derivative
02/22/2012EP2420501A1 Novel compound having 3-heteroarylpyrimidin-4-(3h)-one structure and pharmaceutical preparation containing same
02/22/2012EP2420499A1 1H-benzimidazole-4-carboxamides substituted with a quaternary carbon at the 2-position as potent PARP inhibitors
02/22/2012EP2420496A2 Antiepileptic, hypocholesterolemic and neuroprotective compound
1 ... 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 ... 1595